Parkinson's Disease Progression Study
- Conditions
- Parkinson Disease
- Registration Number
- NCT06219629
- Lead Sponsor
- Koneksa Health
- Brief Summary
Disease Progression Study
- Detailed Description
This is a longitudinal, observational Study to Determine Usability, Analytical and Clinical Validity and Biomarker Discovery for Wearable and Mobile Device Collected Objective Measurement of Disturbed Sleep and Neurologic Disorders. The Disease Progression Study part in Parkinson's Disease has a duration of approximately 12 months.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 82
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Compliance; toolkit assessments Baseline Day 1 through Day 365 End of Participation Percentage of total toolkit tasks completed during the remote data collection period
- Secondary Outcome Measures
Name Time Method Usability; mobile application Baseline Day 1 through Day 365 End of Participation Percentage of participants reporting a mobile application System Usability Scale (SUS) score ≥68
Trial Locations
- Locations (10)
University of Colorado Health Neurosciences Center
🇺🇸Aurora, Colorado, United States
Parkinsons Disease And Movement Disorders Center Of Boca Raton
🇺🇸Boca Raton, Florida, United States
Accel Research Sites DeLand
🇺🇸DeLand, Florida, United States
Accel Research Sites St Petersburg-Largo
🇺🇸Largo, Florida, United States
N1 Research LLC
🇺🇸Orlando, Florida, United States
Augusta University Health Movement Disorder Clinic
🇺🇸Augusta, Georgia, United States
University of Kansas Medical Center Parkinson's Disease and Movement Disorder Center
🇺🇸Kansas City, Kansas, United States
Beth Israel Deaconess Medical Center
🇺🇸Boston, Massachusetts, United States
Quest Research Institute
🇺🇸Farmington Hills, Michigan, United States
Cleveland Clinic
🇺🇸Las Vegas, Nevada, United States